What the 2026 limb-event result does—and does not—say
Actual results described by Kim et al. (2026), reported cessation versus maintained smoking. Relative model estimates, not individual probabilities or proof of restored arteries.
| Result | What the study found | A different claim |
|---|---|---|
| Combined major limb events | Revascularization or major amputation: estimate 0.83 (95% CI 0.73–0.94) | Not a separate 17% reduction in each component |
| Revascularization | The strongest lower association among the limb components | Not direct imaging of plaque disappearing |
| Major amputation | Few events; no statistically clear separate reduction in quitters | Neither guaranteed protection nor proof of no benefit |
Before PAD develops: lower incidence is not a reopened-artery measurement
Ding and colleagues' 2019 ARIC analysis began with 13,355 U.S. adults without PAD, coronary heart disease or stroke. Smoking information was updated during follow-up. Longer cessation was associated with lower newly recorded PAD risk compared with current smoking, while excess risk compared with never smoking remained in some duration groups. A favourable comparison with continuing smoking does not require immediate equality with never smoking.
PAD events were identified from hospitalizations or leg-artery procedures, so mild disease could be missed. Status was self-reported and some missing updates were carried forward; residual confounding remained possible. The duration categories describe this cohort, not a personal ten-, twenty- or thirty-year recovery clock. The study did not repeatedly image an individual's leg arteries to demonstrate clearance of plaque.
After diagnosis: ‘fewer major limb events’ is not ‘fewer amputations by the same percentage’
Kim and colleagues' August 2026 Korean cohort included 189,545 people who smoked before a new PAD diagnosis and attended health examinations before and after it. Reported cessation was associated with a lower combined limb-event estimate than continued smoking. Here the composite meant lower-extremity revascularization—a procedure to restore blood flow—or major amputation. Its adjusted estimate was 0.83, with a 95% confidence interval of 0.73–0.94.
The component results matter: the lower association was strongest for revascularization. Major amputation was uncommon, and the cessation group did not show a statistically clear reduction in that separate outcome. That is not proof of no amputation benefit; it is also not permission to rename the combined result ‘17% fewer amputations’. The table keeps these meanings apart.
The cardiovascular composite was different again: it included death from any cause, heart attack, coronary revascularization and ischaemic stroke—not cardiovascular death alone. The analysis used statistical weighting, not random assignment to quit. Smoking was self-reported without biochemical verification, diagnostic codes were not formally validated in this database, and needing both health examinations selected the population. Other treatment or lifestyle changes could still explain part of the association. It did not establish improvement in walking distance or a disappearance of existing blockage.
Strong support for quitting can coexist with uncertainty about a particular limb outcome
The 2020 U.S. Surgeon General report judged the PAD-specific cessation evidence suggestive but insufficient for its stated causal conclusions, including disease risk and outcomes after diagnosis. The 2024 multisociety guideline strongly recommends supporting cessation, while describing lower limb-event and death rates as observational associations. Trials that show more people stop smoking do not automatically prove an amputation effect. The newer 2026 cohort adds evidence; it is still not randomized proof for every endpoint.
This uncertainty is not a reason to continue smoke exposure. It is a reason to retain appropriate vascular care and ask what an estimate actually measures. New or recurring leg symptoms need professional assessment; symptoms that develop quickly or suddenly worsen require immediate medical attention. Do not treat leg pain or a wound as a sign that quitting is repairing arteries, or postpone care until a cessation anniversary.
For the separate task of stopping smoking, NHS local services provide support in England. They do not replace vascular assessment. This page collects no leg symptoms or smoking history, interprets no ankle–arm readings, and selects no medicine, dose, exercise prescription or procedure.
What to keep in mind
Sources
The central claims on this page were checked against the sources below.
- Journal of the American College of Cardiology: Ding et al. — Smoking cessation and long-term incident PAD in ARIC (2019)
Sources checked: 2026-10-06
- JAMA Network Open: Kim et al. — Smoking Behavior and Major Cardiovascular and Limb Events in Patients With PAD (August 2026)
Sources checked: 2026-10-06
- American Heart Association / American College of Cardiology: Gornik et al. — 2024 multisociety lower-extremity PAD guideline, section 5.4
Sources checked: 2026-10-06
- U.S. Department of Health and Human Services: U.S. Surgeon General — Smoking Cessation (2020), chapter 4 PAD evidence conclusions
Sources checked: 2026-10-06
- NHS: NHS — Peripheral arterial disease (reviewed April 2026)
Sources checked: 2026-10-06
- NHS: NHS — Ready to quit smoking: support in England
Sources checked: 2026-10-06
General population evidence, not personal PAD diagnosis, limb prognosis, test interpretation or treatment. No health or smoking data are collected.